Old Web
English
Sign In
Acemap
>
authorDetail
>
Carlos Aranza Doniz
Carlos Aranza Doniz
Virology
Immunology
Medicine
Immunogenicity
Quadrivalent Influenza Vaccine
4
Papers
87
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Immunogenicity and safety of inactivated quadrivalent and trivalent influenza vaccines in children 18-47 months of age.
2014
Pediatric Infectious Disease Journal
Miguel Angel Rodríguez Weber
Carine Claeys
Carlos Aranza Doniz
Yang Feng
Bruce L. Innis
Varsha K. Jain
Mathieu Peeters
Show All
Source
Cite
Save
Citations (17)
Immunogenicity, reactogenicity, and safety of inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine in healthy adults aged ≥18 years: a phase III, randomized trial.
2014
Vaccine
Juan-Carlos Tinoco
Noris Pavia-Ruz
Aurelio Cruz Valdez
Carlos Aranza Doniz
Vijayalakshmi Chandrasekaran
Walthère Dewé
Aixue Liu
Bruce L. Innis
Varsha K. Jain
Show All
Source
Cite
Save
Citations (60)
© 2012 Landes Bioscience. Do not distribute. The safety profile of Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y tetanus toxoid conjugate vaccine (HibMenCY)
2012
Stephen Rinderknecht
Kristina Bryant
Terry Nolan
Noris Pavia-Ruz
Carlos Aranza Doniz
Miguel Angel Rodríguez Weber
Christopher Cohen
Emmanuel Aris
Narcisa Mesaros
Jacqueline M. Miller
Show All
Source
Cite
Save
Citations (0)
The safety profile of Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y tetanus toxoid conjugate vaccine (HibMenCY).
2012
Human Vaccines & Immunotherapeutics
Stephen Rinderknecht
Kristina Bryant
Terry Nolan
Noris Pavia-Ruz
Carlos Aranza Doniz
Miguel Angel Rodríguez Weber
Christopher Cohen
Emmanuel Aris
Narcisa Mesaros
Jacqueline M. Miller
Show All
Source
Cite
Save
Citations (10)
1